Key points are not available for this paper at this time.
The authors argue that informed consent is ethically necessary in pragmatic trials that randomly assign individual patients to treatments, even when treatment options are within the standard of care. They propose integration of a streamlined consent process into routine practice.
Kim et al. (Wed,) studied this question.